The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CLAMP: A phase II prospective study of camrelizumab combined with pegaspargase, etoposide, and high-dose methotrexate in patients with natural killer (NK)/T-cell lymphoma.
 
Tao Liu
No Relationships to Disclose
 
Qiuhui Li
No Relationships to Disclose
 
Xia Mao
No Relationships to Disclose
 
Haibo Zhou
No Relationships to Disclose
 
Youhong Dong
No Relationships to Disclose
 
Fang Zhu
No Relationships to Disclose
 
Xinxiu Liu
No Relationships to Disclose
 
Gang Wu
No Relationships to Disclose
 
Min Xiao
No Relationships to Disclose
 
Liling Zhang
No Relationships to Disclose